Chronic Heart Failure and Inflammation: What Do We Really Know?
about
Influenza infection and heart failure-vaccination may change heart failure prognosis?IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survivalSequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome.Changes in Circulating Monocyte Subsets (CD16 Expression) and Neutrophil-to-Lymphocyte Ratio Observed in Patients Undergoing Cardiac SurgeryInterdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study.Heart failure is associated with depletion of core intestinal microbiotaNeutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation.Inflammation - Cause or Consequence of Heart Failure or Both?Identification of active components in Yixinshu Capsule with protective effects against myocardial dysfunction on human induced pluripotent stem cell-derived cardiomyocytes by an integrative approach.Inflammation and metabolic cardiomyopathy.From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease.Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure.The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo.Progression of Duchenne Cardiomyopathy Presenting with Chest Pain and Troponin Elevation.Obesity and Cardiometabolic Defects in Heart Failure Pathology.Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice.Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathy.Skeletal muscle alterations in HFrEF vs. HFpEF.Modern iron replacement therapy: clinical and pathophysiological insights.Procalcitonin in heart failure: hic et nunc.platelet-lymphocyte ratio in prediction of outcome of acute heart failure.Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts.Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction.Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases.Distinct roles of resident and nonresident macrophages in nonischemic cardiomyopathy.Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity.Effect of albumin-globulin score and albumin to globulin ratio on survival in patients with heart failure: a retrospective cohort study in China.Cardiomyocytes and Macrophages Discourse on the Method to Govern Cardiac RepairCardioprotection by Cocoa Polyphenols and ω-3 Fatty Acids: A Disease-Prevention Perspective on Aging-Associated Cardiovascular Risk
P2860
Q33708693-1E646F80-6DDE-4AEA-9277-3B65049C0D73Q33797359-AF7F281B-08A8-4D31-BE55-646D82CBD721Q37672722-D7E64A13-FD24-4038-B0AC-AA856580C942Q37699577-6BF1B670-D3B6-4852-9D42-3FB85537647FQ38604382-FD4EB20C-73D4-406A-A55C-0CF683E464BCQ38638181-B61A7C01-D001-4A4B-8A8C-F0A6CC86C287Q38643980-9E843798-B729-40ED-B624-54069B8A0001Q38652174-D02CBCAD-6BF4-493C-B6CC-992EEA3E06FDQ38664204-E07F9A3F-F74D-482B-AC8C-8FC609C5CDADQ38730305-80EC872C-1772-4B83-8DFC-B8283ED28239Q39232024-7B1F9132-60DA-40C6-96F8-7A40605592F7Q39434474-7A8A482B-9B6B-4BD0-9C57-EE6320FBC4C9Q39443668-05BF1753-C116-467B-A49B-ED4C783D71D6Q40058677-BC7D0D2F-DB0B-4D00-B6A3-5FB7BD9F6952Q41653338-6E5696A6-C211-4455-AAC9-025096A2D06FQ41922953-285C49DD-063C-49A5-9FBB-70BFDA4625FCQ41997642-6F70A403-3483-4C81-B8F8-6EFCDCD641E0Q47164860-8BDBA835-76EF-45B7-8B38-A471B949C8C6Q47392961-1EC4D1BF-0872-4A67-B564-F79AA225EF90Q47937684-9EF7EFC1-3FE3-41A6-B552-A75501D4F86CQ49351942-6018338F-0A99-4B61-BBB2-02EB73F370CEQ49613444-998C60DD-72B8-4890-B975-1B27212EF21FQ49668431-E713DB8D-49AD-40B5-889B-710397629606Q49917356-3E12B2C5-4D67-47F9-996E-D75CCA9943C2Q50955643-22E2CADC-3BA9-4FFB-BAFA-B2B962181947Q54261138-71654A2E-6AAA-45E2-90FD-7BFBC134D90AQ54623369-B0206E43-0C67-4695-91FD-6F88A12EA6E9Q55230733-0CC4B8BF-5AF0-40B4-AABA-003FF1AFB35DQ55409994-34B90FFF-7301-4E89-9DA1-A78D021CCCF1Q55690323-F11DBF08-099E-4F68-B530-76B030D1AFD6Q58586099-8669C80D-45ED-4836-9391-E51CA22A68B9Q58730963-37F75D71-3996-4F81-A654-08A8E3D07DAF
P2860
Chronic Heart Failure and Inflammation: What Do We Really Know?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Chronic Heart Failure and Inflammation: What Do We Really Know?
@en
type
label
Chronic Heart Failure and Inflammation: What Do We Really Know?
@en
prefLabel
Chronic Heart Failure and Inflammation: What Do We Really Know?
@en
P1433
P1476
Chronic Heart Failure and Inflammation: What Do We Really Know?
@en
P2093
Sarah A Dick
P304
P356
10.1161/CIRCRESAHA.116.308030
P577
2016-06-01T00:00:00Z